The Global Biological Seed Treatment Market Growth Accelerated By Adoption Of Biological Seed Treatment

Biological Seed Treatment Market
Biological seed treatment products help protect seeds from diseases, pests, and other environmental stresses. Some key advantages of biological seed treatments include reduced dependence on chemical pesticides, improved productivity, and enhanced plant health and vigor.
The global Biological Seed
Treatment Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of biological seed treatment products can be attributed
to rising concerns about sustainable and eco-friendly agricultural practices.
Farmers are increasingly adopting biological seed treatment options like
microbials and botanicals as an alternative to chemical-based seed treatments due
to growing awareness about hazards of pesticide residues. Biological seed
treatments are considered more environment-friendly and helps boost crop
immunity rather than solely relying on pest protection. Organizations are also
educating farmers about various benefits of biological seed treatment through
training programs which is driving its adoption across major cropping regions.
Segment Analysis
The global biological seed treatment market can be segmented into crop type and
treatment type. The crop type segment is further divided into corn, wheat,
soybean, vegetables, and others. The corn sub-segment currently dominates the
market due to its extensive cultivation worldwide and increasing demand for
hybrid corn seeds with biological seed treatment. The treatment type segment is
further classified into microbes, botanical extracts, and others. The microbes
sub-segment holds the largest market share owing to its effectiveness in
improving crop health and productivity.
Key Takeaways
The global Biological
Seed Treatment Market Demand is expected to witness high growth during
the forecast period of 2024 to 2031. The global Biological Seed Treatment
Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to
exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Regional analysis shows that
North America currently dominates the market due to large-scale agriculture and
rising awareness about sustainable farming practices among farmers in the
region. Key players in North America are focusing on innovations and product
launches to consolidate their market position. The Asia Pacific region is
projected to be the fastest growing market for biological seed treatment during
the forecast period. This can be attributed to the increasing agricultural productivity
pressure in densely populated countries such as India and China. Furthermore,
supportive government initiatives for adoption of bio-products in agriculture
are expected to drive the market in the Asia Pacific region.
Key players operating in the biological seed treatment market are Acelity L.P.
Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio
Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences,
Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc.,
Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.
Explore more related article on this topic: https://www.pressreleasebulletin.com/biological-seed-treatment-market-demand/
Explore more related articles: https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/
https://blogger-veritas.blogspot.com/2024/01/the-global-medical-probiotics-market.html
Comments
Post a Comment